Corporate Integrity Agreement Shire

Corporate Integrity Agreement is a legal document that is signed between the United States government and a company. The agreement outlines the obligations and responsibilities of the company towards the government, including ensuring compliance with the law, improving corporate integrity, and preventing fraud and abuse. In recent news, it has been reported that Shire Pharmaceuticals has entered into a Corporate Integrity Agreement with the US government. This article will explore what a Corporate Integrity Agreement is, what Shire did to warrant one, and the consequences of this agreement.

What is a Corporate Integrity Agreement?

A Corporate Integrity Agreement (CIA) is a legally binding agreement between the US government and a company. The agreement is designed to ensure that the company complies with all federal laws and regulations relating to healthcare programs. The CIA outlines the responsibilities and obligations of the company, including compliance with the False Claims Act, Anti-Kickback Statute, and other regulations under the Health Insurance Portability and Accountability Act (HIPAA).

The CIA is a tool that the government uses to promote corporate integrity and prevent fraud and abuse in the healthcare industry. The agreement includes provisions for monitoring and auditing the company`s compliance with the terms of the agreement. Failure to comply with the CIA can result in severe penalties, including fines, exclusion from federal healthcare programs, and criminal prosecution.

What did Shire do to warrant a CIA?

Shire Pharmaceuticals is a global biotechnology company that specializes in developing treatments for rare diseases. The company has been under investigation by the US government for several years for allegedly engaging in illegal marketing practices. Specifically, the investigation focused on Shire`s marketing of its drugs for off-label uses and the payment of kickbacks to doctors and healthcare providers.

In March 2019, Shire agreed to a $350 million settlement with the US government to resolve the investigation. As part of the settlement, Shire entered into a five-year CIA with the US Department of Health and Human Services (HHS) Office of Inspector General (OIG). The CIA requires Shire to implement a comprehensive compliance program, including training and monitoring of employees, reporting of compliance violations, and the engagement of an independent review organization to monitor the company`s compliance.

What are the consequences of the CIA for Shire?

The CIA is a significant consequence for Shire. The agreement requires the company to significantly overhaul its policies and procedures related to compliance, marketing, and sales practices. Shire must also submit regular reports to the OIG on its compliance efforts and cooperate with all government investigations.

The CIA can also impact Shire`s reputation and financial performance. The settlement agreement and CIA are public records, which means that they are available to the public and can be found by potential customers, investors, and partners. The negative publicity associated with the investigation and CIA could damage Shire`s brand and make it more difficult for the company to do business.

In summary, the Corporate Integrity Agreement between Shire and the US government is a serious matter that will impact the company`s operations and reputation. The agreement serves as a reminder that all companies operating within the healthcare industry must comply with federal laws and regulations, and that the government will not hesitate to take action against those who engage in fraudulent or abusive practices. Companies that take proactive steps to prevent compliance violations and maintain corporate integrity will be better positioned to avoid the consequences of a CIA.